Navigation Links
New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
Date:6/8/2008

ir to glargine in a single daily dose over a 24-hour period using continual glucose monitoring system (CGMS), showing that Levemir had a comparable blood glucose response to insulin glargine.

Patients with type 2 diabetes using basal insulin without bolus insulin (N=35) were randomized to receive a single daily injection of Levemir or glargine at 8 p.m. for one week in order to achieve steady state levels of insulin in the body. At the end of the week, subjects were switched to the other insulin.

Both insulins were titrated to achieve blood glucose targets during a pre-specified basal period (12 p.m. to 6 a.m.). No food was eaten between 6 p.m. to ~7 a.m. in order to obtain accurate basal readings.

Once basal blood glucose targets were achieved, CGMS readings for the last 24-hour period were recorded and mean values were compared between treatments using a single-tailed, paired t-test.

Levemir Shows Similar Daily Average Consumption versus Glargine

A retrospective analysis of insulin-naive patients with type 2 diabetes enrolled in a major US health plan compared daily average consumption (DACON) of and glycemic control with the insulins Levemir and glargine, along with associated medical costs. Results showed that there was no difference in HbA1c values between Levemir and insulin glargine cohorts, and no significant difference in DACON.

Researchers monitored insulin-naive patients with type 2 diabetes age 18 and older who were enrolled in a large US health plan. Using propensity score matching, it was found that 48 patients started insulin detemir therapy, and 258 started insulin glargine therapy, over a six-month period. Besides reducing selection bias due to observed baseline characteristics, propensity score matching also ensures that patients in insulin detemir and insulin glargine cohorts have similar distribution of the baseline characteristics. This ensured that patients included in the insulin detemir and insulin gl
'/>"/>

SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
2. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
3. New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study
4. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
5. Study Shows Lantus(R) Helped People Living with Type 2 Diabetes Reach the ADAs Recommended Target for Blood Sugar Control
6. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
7. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
8. Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients
9. Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)...  PARI Respiratory Equipment has won a 2015 American Package ... by the FDA on December 2, is the first co-packaging ... ® Nebulizer for patients with cystic fibrosis. ... into this unique product offering of nebulized drug and device. ... use, we also wanted to convey that the components suit ...
(Date:6/3/2015)... The treatment pipeline for Acute Myeloid Leukemia (AML) ... Research . Analysis from business ... Market to 2020 - forecasts the value of the ... in 2013 to $878.6 million by 2020, representing a Compound ... to treat AML are expected to be approved during the ...
(Date:6/3/2015)... Medical Systems (NYSE: VAR ), world leader in radiotherapy ... the Middle East with the creation ... . Varian Medical Systems Arabia, the result of a ... today at a ceremony attended by local dignitaries and Varian,s ... represents the next step in our commitment both to cancer ...
Breaking Medicine Technology:Kitabis Pak Wins American Package Design Award 2Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 2Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 3Varian Establishes Local Entity in Saudi Arabia to Support Expansion in Middle East 2
... China, March 16, 2011 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore ... the largest retail drugstore chain in China based on the ... results for the fourth quarter and fiscal year ended December ... the quarter ended December 31, 2010: Same store ...
... today announced the appointment of Robert E. Hoffman as ... from Arena Pharmaceuticals Inc., where he held senior financial ... was vice president of finance and chief financial officer. ... of Arena,s initial public offering in 2000 and other ...
Cached Medicine Technology:China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 2China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 3China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 4China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 5China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 6China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 7China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 8China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 9China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 10China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 11China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 12Polaris Group Appoints Robert E. Hoffman as Chief Financial Officer 2
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 ... partnership to expand online and mobile access to ... Review and Maintenance of Certification (MOC) activities. ... market VeoMed’s innovative courses to Decker’s extensive lists ... interested in purchasing access to VeoMed’s premier online ...
(Date:6/3/2015)... June 03, 2015 Peter Piot, MD, ... at DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award ... level of excellence, and commitment to service on a ... President’s Award for Outstanding Contribution to Global Health that ... to advancing global health. , “DIA is ...
(Date:6/3/2015)... The panel of independent experts has spent weeks ... for the awards presented tonight at TU-Automotive Detroit 2015. ... the best-of-the-best can now be revealed as: , Car ... swept rivals aside by taking the coveted Car Maker ... our panel of expert judges., Stand out comments included: ...
(Date:6/3/2015)... 2015 Sitting at a computer for ... the back, neck, shoulders and/or wrists. This can lead ... addition, recent research links sitting for long periods as ... Fortunately, three inventors from Oakville, Ontario, are offering an ... , They have developed a prototype for a patent-pending ...
(Date:6/3/2015)... Acne is the same wherever it appears. But acne ... and hard to prevent. As with acne on the face, ... in the years when the sebaceous glands are most active. ... director and lead medical aesthetician of Simply Posh Aesthetic ... are caused by oil and dead skin clogging the pores ...
Breaking Medicine News(10 mins):Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:TU-Automotive Awards 2015 winners revealed 2Health News:TU-Automotive Awards 2015 winners revealed 3Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:Back Acne: Tips for Clearer Summer Skin 2Health News:Back Acne: Tips for Clearer Summer Skin 3
... stinging pain centered on your forearms, that numbness you experience ... tunnel syndrome (CTS)at all. ,Yes, the CTS, more ... those who work for long hours with their hands could ... say. ,CTS happens when a nerve passing through ...
... A recent study indicates the negative impact of soft drinks ... Connecticut says that consumption// of sugary soft drinks lead to ... ,Brownell and his team after having researched 88 ... of these soft drinks. The research team analyzed 91,000 women ...
... lack the capacity to handle extensively drug-resistant tuberculosis, if ... is said to be resistant to two most potent ... according to some Kenyan medical experts. ... compared with $18,000 to treat multi-drug resistant TB, according ...
... to assess whether meat and dairy products from cloned animals// ... Authority (EFSA) was asked by the European Commission to look ... present, there is no specific regulation on food products from ... year, the US Food and Drug Administration (FDA) concluded that ...
... South Carolina, which will enable the early release of inmates from ... then the prisoners could bring down their stay in the jail ... Anderson who is recommending this legislation opines that the passing of ... in need of organ donors. According to ABC report there are ...
... hailed the progress of governments of Western Pacific countries in ... effort to effectively control the disease. ,The region ... least 70 percent of TB cases and curing at least ... for the health body's TB programme. ,He was ...
Cached Medicine News:Health News:Computer Programmers, need not fear Carpal Tunnel Syndrome 2Health News:EU to Look at Cloned Meat Safety 2Health News:WHO Calls for Greater Efforts to Fight TB 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: